SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cell Therapeutics (CTIC)
An SI Board Since August 1997
Posts SubjectMarks Bans Symbol
946 45 0 CTIC
Emcee:  Regis McConnell Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
871From a BusinessWire issued Zack's PR ... More Bullish Than the Street on CTIan@SI-3/7/2007
870>>Cell Therapeutics, Inc. (CTI) Spin-off to Use Proprietary Recombinant Getuck-2/12/2007
869Pixantrone (BBR 2778) has reduced cardiotoxic potential in mice pretreated with Icebrg-2/9/2007
868OVERVIEW [from 10-Q] We develop, acquire and commercialize novel treatments forIcebrg-2/7/2007
867A funny thing happened on the way to the quorum By Rami Grunbaum, deputy businesIcebrg-2/4/2007
866<i>Cell Therapeutics Announces Reverse Stock Split</i> What would wDewDiligence_on_SI-2/2/2007
865>>Cell Therapeutics, Inc. (CTI) Announces Reverse Stock Split Friday Februtuck-2/2/2007
864Item 8.01. Other Events. Cell Therapeutics, Inc. (the "Corporation") Icebrg-1/23/2007
863Wilder, It was this PR that I believe set the terms for NVS getting either or bIan@SI-1/20/2007
862I'm sure you're right, and I missed it. It figures they'd grant an okeokalani'nui-1/20/2007
861Didn't they already do that? NVS has an option on Pix, if successful. <Ian@SI-1/19/2007
860They are in the same business, issuing shares, after all. A strategic fit with keokalani'nui-1/19/2007
859But CTI has a proven track record of success :-)rkrw-1/19/2007
858Great. Pronounce new symbol loudly "DORC"! Prediction. Company histkeokalani'nui-1/19/2007
857Meanwhile, back in Seattle Bianco has been writing a letter: EX-10.1 3 cticlettIcebrg-1/19/2007
856>>7:00AM Cell Therapeutics files for Special Protocol Assessment With FDA tuck-1/10/2007
855>>Cell Therapeutics, Inc. (CTI) Announces Pixantrone Combination Regimen Ptuck-12/12/2006
854Cell Therapeutics fails to get quorum in Italy By Luke Timmerman Seattle Times bIcebrg-12/2/2006
853La commedia e finita.tom pope-11/4/2006
852This is good. Now they can enrich their study with a subgroup of a subgroup of arkrw-11/4/2006
851Seattle biotech firm halts enrollment in cancer-drug trial By Luke Timmerman SeaIcebrg-11/4/2006
850Maybe one day, they'll quit pouring money down the Xyotax drain... Cell TheIan@SI-11/3/2006
849Sorry, should have backed through thread instead of being lazy. <i>Biancotom pope-10/17/2006
848It depends on your definition of "new". If just shy of a month is ok, Icebrg-10/17/2006
847Erik, Thanks. I must have put that completely out of my memory. The discussioIan@SI-10/17/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News